Mainstream pharma press admits that CRISPR technology failed.
Moments of honesty from the least expected places should be cherished.
If you stand on a river bank and wait for failed gene therapies to float by… you will be flooded! Admission of failure from the pharma propaganda outlets, on the other hand, is a rare event. This washed up in my inbox recently:
“Exclusive: CRISPR delivery startup, based on UC Berkeley and UCSF science, shuts down.”
Keep reading with a 7-day free trial
Subscribe to Due Diligence and Art to keep reading this post and get 7 days of free access to the full post archives.